
Stephanie K. Dougan, MD, assistant professor, Dana-Farber Cancer Institute and Harvard Medical School, discusses the idea of augmenting T cell immunity in tumors that are poorly immunogenic, such as pancreatic cancer.

Your AI-Trained Oncology Knowledge Connection!


Published: November 11th 2018 | Updated: